Karuna Therapeutics Investors

24 investors on Angel Roster list Karuna Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, Canada and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Karuna Therapeutics can appear together.

Investors listed
24
With verified email
46%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 Karuna Therapeutics investors

The most complete profiles first. Showing 24 of 24.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Brad Howlett

    Venture Capital · United States

    AdvertisingHealth CareAutonomous VehiclesE-commerce

    Portfolio: Anaplan, Bridgit, UiPath, Kit Check and 50 more

    Contact details available

  • Chris Eng

    Venture Capital · United States

    AdvertisingHealth CareAutonomous VehiclesE-commerce

    Portfolio: Anaplan, Bridgit, UiPath, Kit Check and 50 more

    Contact details available

  • Heather Preston

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedCredit Industry

    Portfolio: Karuna Therapeutics, Akouos, Carisma Therapeutics, Avalyn Pharma and 4 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Jake Merrill

    Venture Capital · United States

    AdvertisingHealth CareAutonomous VehiclesE-commerce

    Portfolio: Anaplan, Bridgit, UiPath, Kit Check and 50 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

  • Stephen Zachary

    Venture Capital · United States

    AdvertisingHealth CareAutonomous VehiclesE-commerce

    Portfolio: Anaplan, Bridgit, UiPath, Kit Check and 50 more

    Contact details available

  • Steven PaulVerified

    Angel/Individual, Investment Partner · United States

    Health CareBiotechnologyPharmaceuticalsMental Health

    Portfolio: Karuna Therapeutics

    Verified email available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Karuna Therapeutics investors are on Angel Roster?

Angel Roster lists 24 Karuna Therapeutics investors. 11 of them (46%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (23), Private Equity Firms (5) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Karuna Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (7) and Seed (5).

Where are Karuna Therapeutics investors based?

Most are based in the United States (22), Canada (1) and the United Kingdom (1).

Which companies have Karuna Therapeutics investors backed?

The most-backed portfolio companies among them are Akouos (10), Entasis Therapeutics (10), Iterum Therapeutics (9), Chiasma (9) and Auris Medical (9).

How do I contact Karuna Therapeutics investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.